Results 161 to 170 of about 21,592 (229)

Effects of Bisphosphonates on Bone Micro-Architecture of Children With Duchenne Muscular Dystrophy: A Prospective Comparative Study. [PDF]

open access: yesJ Cachexia Sarcopenia Muscle
Wang S   +11 more
europepmc   +1 more source

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis. [PDF]

open access: yesPharmacoecon Open
Flanigan J   +8 more
europepmc   +1 more source

The emerging role of subchondral bone homeostasis in osteoarthritis. [PDF]

open access: yesJ Orthop Translat
Donat A   +5 more
europepmc   +1 more source

Bone Mineral Density After Transitioning From Denosumab to Alendronate [PDF]

open access: yesJournal of Clinical Endocrinology and Metabolism, 2020
Context: There are few studies on patients transitioning from denosumab to bisphosphonates. Objective: To investigate patient characteristics and changes in bone mineral density (BMD) after transitioning from denosumab to alendronate.
David Kendler   +2 more
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

History of alendronate

Bone, 2020
Alendronate was synthesized in 1970s in a search for inhibitors of calcification. Istituto Gentili investigators identified it as a potent inhibitor of bone resorption and obtained a patent covering its use in the treatment of osteoporosis and other disorders of excessive bone resorption in the 1980s.
Steven R. Cummings   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy